openPR Logo
Press release

Fecal Incontinence Therapeutics- Pipeline Analysis 2018

05-23-2019 10:03 AM CET | Health & Medicine

Press release from: Fecal Incontinence Therapeutics- Pharma Proff

Fecal incontinence, also known as accidental bowel leakage, refers to the inability of a person to control bowel movement including stools and mucus. Urge incontinence is a common form of fecal incontinence that occur due to pelvic muscle injury or nerve damage.

Download the sample report at: https://www.pharmaproff.com/request-sample/1026

Passive incontinence is another type of fecal incontinence in which passing of stools is unknown to the patient. Some of the risk factor associated with fecal incontinence are gastrointestinal disorders, such as diarrhoea, constipation, and hemorrhoids.

Get the detailed analysis at: https://www.pharmaproff.com/report/fecal-incontinence-therapeutics-pipeline-analysis

RDD Pharma Ltd. is in the process of developing RDD-0315 as an alpha-adrenergic receptor agonist for the treatment of fecal incontinence. The company has recently completed a successful Phase 2a study of RDD 0315 in fecal incontinence, which reached the primary endpoint (lowered frequency of incontinence events).

Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1026

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fecal Incontinence Therapeutics- Pipeline Analysis 2018 here

News-ID: 1750399 • Views: 244

More Releases for RDD

Anal Fissure Therapeutics Market – Opportunities in Key Application Sectors by …
"Anal Fissure Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 " is the latest addition to MarketResearchReports.Biz industry research reports collection. The objectives of this study are as follows: To define, describe, and forecast the "Anal Fissure Therapeutics " market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges) To
Anal Fissure Therapeutics Market Size will Escalate Rapidly in the Near Future 2 …
Anal fissure is a linear tear in the mucosal lining of the distal anal canal below the dentate line. The common symptoms of an anal fissure include severe pain during and after a bowel movement lasting for several minutes to few hours. These fissures occur mainly because due to trauma to the inner lining of the anus, most of the times a hard, dry bowel movement is typically responsible but
Global Choroidal Neovascularization Drug Market 2018 - Cellphire, Inc., Meabco A …
Apex Market Reports, recently published a detailed market research study focused on the “Choroidal Neovascularization Drug Market” across the global, regional and country level. The report provides 360° analysis of “Choroidal Neovascularization Drug Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Choroidal
Anal Fissure Therapeutics Market Current Trends and Future Aspect Analysis 2017 …
Anal fissure is a linear tear in the mucosal lining of the distal anal canal below the dentate line. The common symptoms of an anal fissure include severe pain during and after a bowel movement lasting for several minutes to few hours. These fissures occur mainly because due to trauma to the inner lining of the anus, most of the times a hard, dry bowel movement is typically responsible but
Anal Fissure Therapeutics Market Growth Opportunities in Industry by 2025
Anal fissure is a linear tear in the mucosal lining of the distal anal canal below the dentate line. The common symptoms of an anal fissure include severe pain during and after a bowel movement lasting for several minutes to few hours. These fissures occur mainly because due to trauma to the inner lining of the anus, most of the times a hard, dry bowel movement is typically responsible but
Research Focused On the Anal Fissure Therapeutics Market Size, Share, Growth, Tr …
"The Report Anal Fissure Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Anal fissure is a linear tear in the mucosal lining of the distal anal canal below the dentate line. The common symptoms of an anal fissure include severe pain during and after a bowel